Salesforce, Inc.

Ticker: CRM

Verdict: Hold · 56/100

Quality

ROE: 12.6%, ROA: 6.6%, net margin: 18.0%

Financial Health

Current ratio: 0.76, D/E: 0.90, interest coverage: N/A

Growth

ROA change: 0.0% YoY, asset efficiency change: 0.0% YoY

Value

Value score: sector ratios vs median (60%) + intrinsic method signal (40%)

Momentum

52-week return: -33.8%, 3-month: -7.1%

Key Questions

Q1: Is Salesforce, Inc. (CRM) a buy?

Verdict: Hold · 56/100. Quality: ROE: 12.6%, ROA: 6.6%, net margin: 18.0%.

Q2: How financially healthy is CRM?

Current ratio: 0.76, D/E: 0.90, interest coverage: N/A

Q3: What is CRM's recent momentum?

52-week return: -33.8%, 3-month: -7.1%

Q4: What is CRM's growth like?

ROA change: 0.0% YoY, asset efficiency change: 0.0% YoY

Q5: What is the investment thesis for Salesforce, Inc.?

Value score: sector ratios vs median (60%) + intrinsic method signal (40%)